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Epidemiology of Toluene Oiisocyanate (TOI)-
Induced Respiratory Disease
by John M. Peters* and David H. Wegman
*
This paper describes our experience with the respiratory effects of TDI. Five
respiratory reactions attributable to TDI are described with supporting evidence.
The reactions are sensitization, irritation from overexposure, acute loss of ventilatory
capacity, accelerated loss of pulmonary function and induction of a general asthmatic
state. Evidence is presented that suggests a safe exposure level.
In our plastic world, polyurethanes have
achieved great commercial importance. The
production of polyurethane involves the com-
bination of chemicals containing two highly
reactive isocyanate groups with a polyol. It is
during this mixing and foaming process that
the isocyanates are evolved into the workroom
atmosphere. Depending on plant configuration
and ventilation, few or many worlwrs can be
exposed. Other significant exposures may occur
in industrial chemical laboratories and during
repair or cleaning of the equipment. The prod-
ucts are used primarily as cushioning materials
(mattresses, pillows, seat cushions, and pack-
ing materials), for insulation (thin-walled re-
frigerators and ovens), for soft toys, and for
surface coatings (varnishes and paints).
The diisocyanates have been of concern to
industrial toxicologists since the 1940's, and
the first clinical report of health consequences
appeared in 1951 (1). Since that time, cases
have been reported from many parts of the
world. The clinical features were admirably
summarized in 1963 (2). Toluene diisocyanate
(TDI) is the most commonly used isocyanate;
unfortunately, because of its volatility it is
also the most hazardous.
In many affected workers the characteristic
pattern of bronchial asthma is present as the
initial manifestation. Overexposures to TDI,
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usually as the result of accidental spills, will
almost invariably produce respiratory irrita-
tion. Often eye, nose, and throat irritations are
the first clinical manifestations. Dry cough with
chest pain or tightness follow. The cough is
characteristically worse in the evening or at
night, often obscuring its occupational cause.
Chest x-rays taken during the acute stage are
usually interpreted as normal, although in-
creased markings and patchy infiltrates are
occasionally seen. The clinical picture can then
approximate bronchitis, bronchiolitis, bronchial
asthma, or pneumonitis.
After exposure stops, recovery is usually
rapid. With re-exposure to even minimal
amounts of TDI, workers manifesting bron-
chospasm may experience a worsening of
symptoms, can no longer tolerate exposure and
leave the industry.
We became interested in workers who did
not leave the industry but who stayed and
were continuously exposed to low levels of
TDI. Gandevia's observation (3) that rela-
tively high concentrations of TDI produced
workshift loss of ventilatory capacity prompted
us to look for this reaction at "safe" levels.
Of 38 workers, 34 experienced decreases in
forced expiratory volume in 1 sec (FEV1)
while peak air concentrations for TDI were
0.003 ppm (0.02 ppm is considered the safe
ceiling level). Workers exposed to TDI, in
contrast to cotton workers, had no chest tight-
ness or shortness of breath while sustaining
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decreases of as much as 1.8 liters in FEV1
have been observed over one workshift (4).
The question of whether long-term, low-level
exposure to TDI produces chronic pulmonary
impairment has received recent attention.
McKerrow, Davies, and Jones (5) examined
22 men who had 2.7 yr average exposure to
low levels of TDI and found that of several
pulmonary function tests the FEVY was de-
pressed below predicted normal. Hill (6) noted
that bronchitis was more common among work-
ers exposed to isocyanates than among controls.
Adams (7) observed annual deterioration of
vital capacity (FVC) and FEV1 exceeding that
expected from aging.
Our approach to determining the possible
chronic effects of TDI was the following. When
the data on ventilatory capacity from cross-
sectional and longitudinal studies of pulmonary
disease are examined, some very interesting
facts are revealed. First, groups, unlike indi-
viduals, behave in a very predictable way.
Table 1 summarizes and simplifies this idea.
Several studies have revealed that an expected
decrement for FEV, for a normal population
is about 25 ml/yr. Whether this decline is per-
fectly linear over a life span is arguable, but
the available data suggest that it approximates
linearity. If one extrapolates this 25 ml/yr
loss for 40 yr (approximately a man's working
lifetime), one can see that at age 20 the FEVY
is 4.0 liters and at age 60 the FEV1 is 3.0
liters. The FEV1, representing an index of
the capacity of the lung, is a potentially power-
ful tool for determining the chronic disease
potential of a given occupational exposure.
This is particularly so for diseases which are
largely dose-dependent and/or those in which
host variability is relatively unimportant and
Table 1. Expected decrement in ventilatory capacity.
Decrement FEV, liters
in FEV1,
1./yr Age 20 Age 60
Normals 0.025 4.0 3.0
Chronic obstructive lung
diseaseb 0.080 4.0 0.8
* Data of Kory (8), Ferris (9), Rosenzweig (10), Fletcher
(11), Higgins (12), Morris (18).
b Data of Medical Research Council (14), Howard
(15), and Burrows (16).
for which no other special diagnostic charac-
teristic appears early in the course of the
disease.
In contrast to normal losses the annual decre-
ment for patients with chronic obstructive lung
disease is much greater as seen in several
studies conducted in Great Britain and the
United States (see Table 1). It would appear
from these studies that the development of
chronic obstructive lung disease is a slow, in-
sidious process taking many years to develop,
especially when observed in a population of
affected persons. The FEVY decrements in these
groups of sick persons range from 0.079 to
0.084 I./yr. If one extrapolates again from
age 20, at which time the FEVY is approxi-
mately 4.0 liters, to age 60, the FEV1 has fallen
to 0.8 liters.
With these facts in mind we followed a co-
hort of workers exposed to low levels of TDI
for 3 yr. We measured their ventilatory capac-
ity annually on a Monday morning after a
weekend of no exposure and before exposure
had begun on that day.
At one year we found a fall of 0.12 liters
in the FEVY. A similar decrement was ap-
proximated in the second year, and by the end
of the third year it was clear that the decre-
ment was a persistent 120 ml/yr.
It is clear that this rate of decrement is
excessive and strongly suggests that TDI has
a chronic disease potential. In addition the acute
reaction seen over one shift correlates highly
with subsequent long-term decrement (r =
0.71). This has important implications for the
screening, control, and surveillance of exposed
workers. It is also a large enough correlation
for a safe level of continued exposure to be
estimated on the basis of acute reactions to
TDI.
The correlation between acute, workshift
decreases in FEV1 and cumulative decrements
over 3 yr led to a study designed to examine
the possible dose-response relationship for
acute effects.
A total of 111 workers exposed to TDI were
examined during a work shift. Their ventilatory
capacity was measured before and after the
shift on a Monday. Their exposures ranged
from 0.002 ppm to 0.013 ppm. Workers were
divided into four groups over this exposure
range. All four groups demonstrated significant
declines in FEV1 with the magnitude of de-
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(Table 2). ventilatory capacity (FEVY), males only.,
Table 2. Levels of TDI exposure.
Mean TDI Mean change
concentration, Group n in FEVY, SD p
ppm liters
0.002 A 51 0.078 0.173 0.01
0.003
0.004 B 24 0.112 0.155 0.01
0.005 C 19 0.106 0.165 00.2
0.006
0.007
0.009 D 17 0.180 0.185 0.01
To verify this, a stepwise regression analysis
was performed which revealed one independent
variable to contribute significantly to the ex-
planation of variance. That factor was magni-
tude of exposure (Table 3).
Table 3. Stepwise regression analysis for determinants of
mean change in FEV1.
Independent variable Magnitude of (Constant)
exposurea
Bb 0.014 0.048
SE of B 0.066
p2 0.04
F value 4.70
p 0.05
Analysis of variance
D=1
Sum of squares 1,331.5
Mean square 1,331.5
F 4.70
D =109
Sum of squares 30,883.6
Mean square 283.3
^ No other variable was significant determinant.
b Positive value denotes negative mean change in FEVY.
In an attempt to gain some insight into the
mechanism and possibly to determine which
workers would be most likely affected by ex-
posure to TDI, we measured circulating eosino-
phil levels Monday morning prior to exposure
and again on Wednesday morning. On the same
workers, FEV1 was measured before and after
their Monday shift. There was a statistically
significant rise in absolute eosinophil count and
a statistically significant fall in FEV1. The
two were correlated (Table 4).
Unfortunately, knowledge of the eosinophil
level prior to exposure to TDI was not pre-
dictive of the magnitude of decrease in FEV1.
Eosinophils
Decrease Increase
FEVY increase 8 3 11
FEVY decrease 5 14 19
13 17 30
xI =4.37, p<0.05
We conclude that while eosinophils may be
involved in the mechanism of pulmonary re-
sponse leading to change in ventilatory capacity,
the use of eosinophil counts in surveillance of
workers exposed to TDI does not appear useful.
Another important observation concerns
what appears to be the induction of a general
asthmatic state by TDI. Some workers "sensi-
tized" to TDI appear to be specifically reactive
only to TDI such that cessation of exposure
solves their bronchospastic problem. On the
other hand, we have seen several workers
"sensitized" to TDI in whom a general asth-
matic state exists. Following the induction of
this state the individuals behave as ordinary
asthmatics being affected by pollens, smoke,
cold, anxiety etc. These cases frequently occur
in persons with no personal or family history
of atopy. The "natural" incidence of adult-
onset asthma is not known but it seems clear
that excessive numbers come from populations
exposed to TDI.
Summary
It appears that there are at least five describ-
able patterns of respiratory reaction to TDI.
They are not necessarily mutually exclusive.
The first and most widely recognized is that
of TDI sensitization. In our experience ap-
proximately 2.5%o of workers exposed to "safe"
levels will develop asthmatic symptoms each
year. Following development of this state, no
further exposure to TDI is tolerable.
Another respiratory reaction is that of chem-
ical bronchitis following overexposure usually
as a result of an accident. Sensitization as de-
scribed above does not necessarily follow.
The fall in ventilatory capacity seen over a
workshift constitutes another reaction to TDI
and because of its correlation with accelerated
June 1975 99loss of pulmonary function described below,
is important for screening and surveillance of
workers.
TDI appears to accelerate loss of pulmonary
function. Prolonged exposure could thus re-
sult in the indidious development of chronic
obstructive lung disease.
The incidence of adult-onset asthma appears
to be excessive from populations exposed to
TDI.
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